Extract notice to the Minister

Dupixent (MPOC)

Common name / Subject : dupilumab
Name of the manufacturer : SanofiAven
Form : Sol. Inj. S.C. (ser/stylo)
Dosage : 150 mg/ml (2 ml)

Indication : Maladie pulmonaire obstructive chronique

INESSS' Recommendation
Refus d'inscription - Ensemble des aspects

Minister's decisions
À venir

Evaluation published on December 03, 2025

INESSSid: 26002
Recevable on February 10, 2025

Download Advice to minister about Dupixent (MPOC)

Extrait d'avis au ministre sur Dupixent(MPOC) 861 KiO

Subscribe to our newsletter now

Subscription